MedPath

Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007

Terminated
Conditions
Menstruation Disturbances
Eating Disorder
Bone Loss
Registration Number
NCT01183377
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Women's evermore presence in professional and athletic sports has revealed sound evidence on the existence of female athlete triad among the world's elite female athletes. This triad consists of eating disorders, amenorrhea and osteoporosis. It has been stated that all female athletes are potentially at risk, but it is not clear to what extent those exercising at different levels are at risk of this syndrome/triad. Since the manifestation of this triad is often denied, or under-reported, appropriate screening methods are required to identify the symptoms. There is still no clear-cut information available on the incidence of this triad in Iran. And there are religious and cultural differences between Iran's elite female athletes and those in other countries. Therefore, in order to meet Iranian female athletes' needs, the investigators decided to determine the frequency of the female athlete triad in Iran.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • All Elite Female athletes who play in international teams in sport federation or champion Team in Tehran between 13-45 years old.
Exclusion Criteria
  • The 13-15 year old female athletes who are not manarch with secondary sex charactristics.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of Female Athlete Triad among Elite female athlete in Iran in 200624 month
Secondary Outcome Measures
NameTimeMethod
prevalence of menstrual disorder in female athlete in Iran in 200624 month

Trial Locations

Locations (1)

Rheumatology Research Center, Shariati Hospital

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath